PREDICTIVE ONCOLOGY INC(NASDAQ:POAI) stock News

POAI Latest News, Press Relases and Analysis

All

Press Releases

15 days ago - By: Chartmill - Mentions: SANM AMD XELB ASNS ...

Wondering what's happening in today's pre-market session?

7 days ago - By: Predictive Oncology Inc.

Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy

7 days ago - By: Predictive Oncology Inc.

Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy

8 days ago - By: Benzinga - Mentions: NDRA ADTX NBTX FORA ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

13 days ago - By: Predictive Oncology Inc.

Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy

13 days ago - By: Predictive Oncology Inc.

Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy

21 days ago - By: Stocktwits - Mentions: VXF

Predictive Oncology Stock Receives Significant Investor Interest Today – Here Are Two Important Developments

22 days ago - By: Benzinga - Mentions: MSS MLTX KALA IOBT

Nasdaq Jumps 150 Points; US Pending Home Sales Rise

22 days ago - By: Predictive Oncology Inc.

Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens

22 days ago - By: Predictive Oncology Inc.

Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens

26 days ago - By: Stocktwits - Mentions: VXF

Predictive Oncology Shares Tumble 19% On Reverse Stock Split Announcement – More Details Inside

a month ago - By: Predictive Oncology Inc.

Predictive Oncology Announces 1-for-15 Reverse Stock Split

a month ago - By: Predictive Oncology Inc.

Predictive Oncology Announces 1-for-15 Reverse Stock Split

2 months ago - By: Predictive Oncology Inc.

Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients

2 months ago - By: Predictive Oncology Inc.

Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients

2 months ago - By: Kahn Swick & Foti, LLC - Mentions: RENB

PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

2 months ago - By: The Motley Fool

POAI Reports Earnings

2 months ago - By: Predictive Oncology Inc.

Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update

2 months ago - By: Predictive Oncology Inc.

Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update

3 months ago - By: Predictive Oncology Inc.

Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities

3 months ago - By: Predictive Oncology Inc.

Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities

4 months ago - By: Predictive Oncology Inc.

Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing

4 months ago - By: Predictive Oncology Inc.

Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing

4 months ago - By: Predictive Oncology Inc. - Mentions: LH

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

4 months ago - By: Predictive Oncology Inc.

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

5 months ago - By: Predictive Oncology Inc.

Court Denies Renovaro Motion for an Expedited Trial in July

5 months ago - By: Predictive Oncology Inc.

Court Denies Renovaro Motion for an Expedited Trial in July

5 months ago - By: Stocktwits - Mentions: RENB

Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish

5 months ago - By: Renovaro Inc - Mentions: RENB

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

5 months ago - By: Renovaro Inc - Mentions: RENB

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

5 months ago - By: Predictive Oncology Inc.

PREDICTIVE ONCOLOGY INC (POAI) Stock News

POAI Latest News, Press Relases and Analysis

Wondering what's happening in today's pre-market session?

Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy

Predictive Oncology Announces Additions to Board and Leadership Team to Support Digital Asset Treasury Strategy

12 Health Care Stocks Moving In Monday's Pre-Market Session

Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy

Predictive Oncology Inc. Announces Closing of $343.5 Million in Private Placements to Initiate Digital Asset Treasury Strategy

Predictive Oncology Stock Receives Significant Investor Interest Today – Here Are Two Important Developments

Nasdaq Jumps 150 Points; US Pending Home Sales Rise

Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens

Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens

Predictive Oncology Shares Tumble 19% On Reverse Stock Split Announcement – More Details Inside

Predictive Oncology Announces 1-for-15 Reverse Stock Split

Predictive Oncology Announces 1-for-15 Reverse Stock Split

Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients

Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients

PREDICTIVE ONCOLOGY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI

POAI Reports Earnings

Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities

Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx® and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities

Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing

Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp

Court Denies Renovaro Motion for an Expedited Trial in July

Court Denies Renovaro Motion for an Expedited Trial in July

Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish

UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition